Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001415889-23-000837

EXEC. VP AND CLO sold 835 shares at $41.66 ($34,783)

From the SEC's structured data for this filing

Trades in this filing

Boulding Mark Elliott · EXEC. VP AND CLO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-01-09 Sale : show line 1 in the form −835 $41.66 $34,783 77,275 D
Open-market sales · 835 sh · avg $41.66 · $34,783
Loading xslF345X03/form4-01112023_110127.xml…